Improved Treatment of Balance Disorders
Submitting Institution
Imperial College LondonUnit of Assessment
Clinical MedicineSummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Clinical Sciences, Neurosciences, Public Health and Health Services
Summary of the impact
Dizziness is a common presenting symptom in general practice, neurology,
ENT and old age medicine. Chronic dizziness in particular has a major
impact on the individual and health service resources. Imperial College
researchers have shown that the best treatment, from primary to tertiary
care, is balance rehabilitation. Imperial researchers have provided the
scientific basis for understanding a common form of chronic dizziness
triggered by visual movement, which we labelled and is now known as
"visual vertigo". We have developed an effective desensitization treatment
program for this condition which is acknowledged in a Department of Health
(DoH) "Good practice guide" document in 2009. The new desensitization
treatment has now been adopted by rehabilitation professionals worldwide.
Underpinning research
Key Imperial College London researchers:
Professor Adolfo Bronstein, Professor of Neuro-otology (2001-present)
Professor Lucy Yardley, post-doctoral researcher (1995-1998), now at
Southampton University
Professor Michel Guerraz, research assistant (1998-2002), now at
Universite de Savoie
Dr Marousa Pavlou, PhD student (2002-2005), now at King's College London
After headache, dizziness is the second most frequent neurological
presentation in general practice. It is estimated that 1/4 of adults in
the UK have significant dizziness at any given time (DoH 2009 document [1]
Evidence section). Chronic dizziness, in particular, has a major impact on
the individual's well-being and working capacity, for example, 27% change
their jobs and 21% give up work as a result (1). Vestibular and balance
rehabilitation is the best treatment with nearly 70% of individuals
completing a customised program achieving significant improvements (DoH
2009 document [1] Evidence section). However, Professor Bronstein and
colleagues noticed that rehabilitation efficacy was compromised both by a)
the pre-conception that rehabilitation cannot be implemented in primary
care due to infrastructure limitations and b) the fact that no
rehabilitation program existed for patients not responding to conventional
hospital treatments — particularly for chronic patients with dizziness
prompted by disorienting visual surroundings ("visual vertigo").
We tackled these two problems by a) identifying the scientific basis of a
hitherto poorly defined form of dizziness, `visual vertigo', where chronic
dizziness is aggravated by visual movement (e.g. busy supermarkets,
driving) and b) by developing appropriate rehabilitation strategies, both
at primary and tertiary care level.
First, in 2001, Professor Bronstein and colleagues examined chronic
patients' physiological responses to visual motion stimuli and found that
such symptoms arise from a form of defective multisensory integration
called "enhanced visual dependency" (2). Essentially, spatial orientation
in these difficult patients is unduly influenced or biased by disorienting
visual scenes in the environment (2-3). This work provided the scientific
basis for developing rehabilitation randomized controlled trial (RCT)
using visual motion desensitization (4). In this RCT, we compared
hospital-based state of the art rehabilitation (customised exercise
regime) with our new treatment using visual motion desensitization, which
included exposing patients to simulated motion. The results showed
significantly superior results in patients utilising the new regime
incorporating simulated motion treatment. Encouraged by our observations
with the hospital population, we also developed rehabilitation solutions
for primary care by training existing GP surgery nurses to do balance
rehabilitation. We found that a single training session with GP nurses
made them capable of implementing a rehabilitation program which led to
significantly superior outcomes when compared to standard GP treatment,
typically drugs (5).
References to the research
(1) Bronstein, A.M., Golding, J.F., Gresty, M.A., Mandalà, M., Nuti, D.,
Shetye, A., & Silove, Y. (2010). The social impact of dizziness in
London and Siena. J Neurol, 257, 183-190. DOI.
Times cited: 10 (as at 7th November 2013 on ISI Web of
Science). Journal Impact Factor: 3.4
(2) Guerraz, M., Yardley, L., Bertholon, P., Pollak, L., Rudge, P.,
Gresty, M.A., & Bronstein, A.M. (2001). Visual vertigo: symptom
assessment, spatial orientation and postural control. Brain, 124,
1646-1656. DOI.
Times cited: 85 (as at 7th November 2013 on ISI Web of
Science). Journal Impact Factor: 9.4
(3) Bronstein, A.M. (2002). Visual and psychological aspects of
vestibular disease. Curr Opin Neurol, 15, 1-3.DOI.
Times cited: 5 (as at 7th November 2013 on ISI Web of Science).
Journal Impact Factor: 4.9
(4) Pavlou, M., Lingeswaran, A., Davies, R.A., Gresty, M.A., &
Bronstein, A.M. (2004). Simulator based rehabilitation in refractory
dizziness. J Neurol, 251, 983-995. DOI.
Times cited: 49 (as at 7th November 2013 on ISI Web of
Science). Journal Impact Factor: 3.4
(5) Yardley, L., Donovan-Hall, M., Smith, H.E., Walsh, B.M., Mullee, M.,
& Bronstein, A.M. (2004). Effectiveness of primary care-based
vestibular rehabilitation for chronic dizziness. Ann Intern Med,
141, 598-605. DOI.
Times cited: 52 (as at 7th November 2013 on ISI Web of
Science). Journal Impact Factor: 16.7
Key funding:
• Medical Research Council (MRC; 2001-2005; £280,000), Principal
Investigator (PI) A. Bronstein, Visual, cervical and autonomic influences
on balance controI mechanisms.
• MRC (2006-2011; £2.4million), PI A. Bronstein, Mechanisms Determining
Chronic Vestibular Symptoms.
• MRC (2012-2015; £800,000), PI A. Bronstein, Cortical function in visual
dependency in patients with chronic dizziness.
Details of the impact
Impacts include: health and welfare, practitioners and services, public
policy and services Main beneficiaries include: patients, health
practitioners, DoH
Chronic dizziness affects millions of people worldwide. Professor
Bronstein and colleagues defined Visual Vertigo and developed
desensitization treatments which are recommended by DoH and used by
balance professionals worldwide. In the DoH "Provision of adult balance
services: a good practice guide", the impact of the rehabilitation RCT is
acknowledged, as a recommendation [1]: "It has been shown that certain
balance symptoms (e.g. visual vertigo) do not respond to physical
exercises alone; but in combination with dynamic visual stimulation,
significant improvements are noted (41) Evidence suggests that mechanical
and novel physiotherapy interventions such as virtual reality (42) and
visual flow stimulation can promote improved vestibular compensation and
rehabilitation, particularly when the patient experiences visual vertigo.
Supra-specialist balance centres should have access to such equipment."
(Note Reference 41 in the DoH document is reference (4) above).
A more recent Cochrane review (2011) on Vestibular Rehabilitation [2],
also acknowledges the positive effect of our "simulator-based visual and
self-motion stimulation" programme from our RCT (reference (4), as above).
The results of our RCT led to lectures and practical workshops for
practitioners at medical and physiotherapy meetings in the UK and
worldwide (two recent ones were in February 2012 at the American Physical
Therapy Association, and UK National Vestibular Therapy Meeting May 2012)
[3]. It must be emphasised that the latter events are `hands on' `how to
do it' sessions for rehabilitation professionals with a massive projection
to the ultimate beneficiaries, the patients.
In the UK, the majority of balance physiotherapists now actively treat
visual vertigo symptoms. A survey amongst the 101 therapists attending the
National Vestibular Therapy Meeting (London, May 2012) showed that in
response to the question "When present, do you treat visual vertigo
symptoms: 86% = yes; 14% = no [3]. It should be noticed that before our
research there was no concept of how dizziness (an `ear' problem) could
possibly be aggravated by visual stimuli (an `eye' situation). More
importantly, there was no structured treatment for such difficult dizzy
patients. There is further evidence that physiotherapists are using and
teaching our treatment approach, e.g. see J Beyts (UCLH vestibular
therapist) lecture to Royal Surrey NHS Trust, with her slides showing our
findings and treatment techniques [4].
The geographical reach of our impact extended to the USA. At a meeting of
the ICF Consensus Conference for Vertigo (Kloster Seeon, Munich, May 2012)
Professor S Whitney, chairperson of the Vestibular Special Interest Group
of the American Physical Therapy Association (APTA) reported that of the
approximately 3000 vestibular therapists in the USA, 70% use visual motion
treatments as developed by Imperial for patients with chronic dizziness
and visually-induced symptoms. In fact, the American Physical Therapy
Association "Patient Education Fact Sheet" describes the syndrome of
`visual vertigo', using the term we coined, our interpretation and
treatment principles [5]. They also have a dedicated podcast (aimed at
physiotherapists but open to the public) on "Visual Vertigo" and "High
Tech Vestibular and Balance Gadgets" in which the team at Imperial College
is specifically mentioned [6]. The treatment DVD that we devised and
copyrighted is also discussed. Imperial College is copyrighting and
publishing this DVD in November so it can be easily available for patients
and therapists. A deed of Assignment has been signed and this DVD will be
commercialised through Imperial Innovations Ltd.
Sources to corroborate the impact
[1] The DOH "Provision
of adult balance services: a good practice guide", 2009
[2] Hillier, S.L., McDonnell, M. (2011). Cochrane Review: Vestibular
rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane
Database Syst Rev, 2011 (2), CD005397. DOI.
[3] National Vestibular Therapy Meeting Survey, London, May 2012. Full
results of the poll can be found in the webpage of the British Society of
Neuro-otology, http://www.bsno.org.uk.
Archived
on 7th November 2013.
[4] Example of lecture to Royal Surrey NHS Trust, showing our findings
and treatment techniques: http://www.royalsurrey.nhs.uk/visual_vertigo_management_slide_2011.
Archived
on 7th November 2013.
[5] The American Physical Therapy Association "Patient Fact Sheet" on
"Visual Vertigo and Motion Sensitivity": http://www.neuropt.org/docs/vsig-physician-fact-sheets/visual-vertigo-motion-sensitivity.pdf?sfvrsn=2.
Archived
on 7th November 2013.
[6] Podcasts: http://www.neuropt.org/special-interest-groups/vestibular-rehabilitation/podcasts
(podcast #2 — "Visual vertigo" and podcast #6: High Tech Vestibular and
Balance Gadgets mins. 26-36). Archived
on 7th November 2013.
Contacts to corroborate the impact claimed:
Chairperson for the Neurology Vestibular Special Interest Group, American
Physical Therapy Association